We have a track record of working with top pharmaceutical corporations and leading academic institutions to foster valuable innovation. We are eager to collaborate closely with partners to broaden the impact of our REVEAL™ Exosome Therapeutics platform across a diversity of disease areas.
We are dedicated to developing targeted exosome therapies and are seeking core partnerships to accelerate their development and enable their commercialization. Contact us to discuss opportunities to work closely with our team of world-class exosome scientists, engineers, and data scientists.
Collaborate with Mantra to explore how REVEAL can make an impact on your drug development pipeline.
Engage in licensing opportunities of Mantra Bio’s patented library of Targeted Exosome Vehicles (TEVs) for drug delivery towards specific targets.
Co-develop with Mantra Bio to bring best-in-class medicines to patients.
We are excited to collaborate with companies with deep indication expertise and complementary capabilities in regenerative medicine, metabolic and cardiovascular disorders, rare diseases, neurodegenerative disease, and more.